A Study of ORTD-1 in Patients Hospitalized With COVID-19 Related Pneumonia

Withdrawn before enrolling · Phase 1/Phase 2

Conditions studied: COVID-19

In brief

Evaluate the safety and effect of ORTD-1 on COVID-19 related pneumonia.

Key facts

Study ID

NCT04708236

Run by

Oryn Therapeutics, LLC

People needed

0

Starts

2021-04-01

Expected to finish

2021-07-01

Last updated by the study team

2021-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Positive RT-PCR assay for SARS CoV-2 in a respiratory tract sample
• Hospitalized for COVID-19
• Radiographic diagnosis of pneumonia
• Respiratory insufficiency
• Receiving pharmacologic thromboprophylaxis

You may not qualify if…

• Premorbid abnormal pulmonary function or disease
• Concurrent or prior intubation or ventilated support for COVID-19
• Receiving systemic corticosteroids or other immunomodulators or immunosuppressant drugs
• Previous hospitalization for COVID-19

Where it is running

• UC Irvine Medical Center — Orange, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.